Renegade drew the No. 1 post position but is still the 4-1 morning-line favorite for the 152nd Kentucky Derby. Only three ...
FDA accepted an RTOR sBLA and granted priority review for zanidatamab-hrii combinations as first-line therapy in HER2+ ...
After the Boston Celtics rolled in Philadelphia and the San Antonio Spurs roared back in Portland, the No. 2 seeds in the NBA ...
FDA reviews Ziihera combinations for HER2-positive gastroesophageal cancer, showing potential benefit as a first-line ...
Experience a burst of citrusy, sweet-and-sour flavors with Spicy Marmalade Chicken and Sweet Potatoes, a sheet-pan dish ...
Special releases are available from Blanton’s at Buffalo Trace, Woodford Reserve, Four Roses, Evan Williams and Maker’s Mark.
Zanidatamab plus chemotherapy with or without tislelizumab significantly improves progression free survival in first-line ...
The firm is planning to begin a Phase III study evaluating zovegalisib, atirmociclib, and an aromatase inhibitor in early 2027.
Nvidia shares popped to an all-time high on Monday – its first since last October – but the chip giant's performance has been ...
NHL.com's fantasy staff continues to cover the latest trends and storylines in the League through the lens of NHL EDGE puck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results